Abstract:Background and Aims Epidemiological studies show that high circulating cystatin C is associated with risk of cardiovascular disease (CVD), independent of creatinine-based renal function measurements. However, the relationship between serum cystatin C level and coronary atherosclerotic plaque burden is limited. We aimed to evaluate the relationship between circulating cystatin C and coronary atherosclerotic plaque burden. Methods This study was a cross-sectional study based on China community population. Measurements of plaque burden were based on the segment-involvement score (SIS) and segment stenosis score (SSS), which derived from the Coronary Artery Tree Model Depicting Coronary Artery Plaque Scores. Logistic regression model was used to demonstrate the association between cystatin C level and coronary artery plaque burden. Mendelian randomization (MR) analyses were conducted to assess the causal effect of cystatin C level on coronary atherosclerosis risk. Results A total of 3,043 objects were included in the present study. The odds risks (OR) of severe plaque burden in the highest serum cystatin C levels (OR: 2.50; Cl:1.59–3.91; P < 0.001) and medium-level cystatin C levels (OR: 1.86; 95% Cl: 1.21–2.88; P = 0.005) were significantly higher after fulled adjusted confounders compared with the lowest levels of serum cystatin C by SSS. The MR analysis showed that genetic predicted cystatin C levels was associated with an increased risk of coronary atherosclerosis (OR, 1.004; 95% CI, 1.002–1.006, P < 0.001) . Conclusion Elevated serum cystatin C levels were associated with coronary atherosclerotic plaque burden. Cystatin C levels had a causal effect on an increased risk of coronary atherosclerosis at the genetic level. What is already known on this topic? Coronary artery disease is currently the most common cardiovascular disease and the leading global cause of mortality. Previous studies reported that higher serum cystatin C levels were associated with an increased risk for future cardiovascular events, independent of the normal creatinine levels or estimated glomerular filtration rate (eGFR) values. The presence of high-risk coronary atherosclerotic plaque burden is associated with increased risk of cardiovascular events. However, the association between serum cystatin C and coronary atherosclerotic plaque burden is not very clear. What this study adds? Our study demonstrated that the elevated serum cystatin C levels were associated with coronary atherosclerotic plaque burden. In addition, we found that serum cystatin C levels had a causal effect on an increased risk of coronary atherosclerosis at the genetic level. How this study might affect research, practice or policy? Current research finds that serum cystatin C levels were associated with coronary atherosclerosis. The metabolic pathway of cystatin C could be a target for new therapies against CAD.

Correlation of Serum Levels of Cystatin C and High-Sensitivity C-reactive Protein with Coronary Atherosclerotic Plaque Burden

The study on the relationship between the level of serum CysC and atrial fibrillation in patients with acute cerebral infarction

Relationship Between the High-Sensitivity C-reactive Protein,cardiac Troponin I and Severity of Coronary Lesion

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

The Impact of Serum Cystatin C on Short Term Prognosis in Petients With Ischemic Heart Failure

Study in the relationship between severity of coronary artery disease and high sensitive-C reaction protein as well as insulin resistance

Correlation Between Serum Uric Acid Levels and Coronary Plaque Characteristics on Optical Coherence Tomography.

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

Correlation between cystatin C and severity of coronary artery lesions in patients with suspected coronary heart disease

Correlation Between Cystatin C Level and Coronary Heart Disease

Relationship between C-reactive protein level and angiographical characteristics of coronary atherosclerosis

AS-272 the Research of the Association among Plasma Concertration of Cystatin C, C-reactive Protein and Coronary Artery Disease

Correlation of Glycated Hemoglobin,fibrinogen and Cystatin C with the Severity of Coronary Artery Lesions in Non-Diabetic Patients

Association of Serum Cystatin C Level with Coronary Atherosclerotic Plaque Burden: a Comprehensive Analysis of Observational Studies and Genetic Study.

Study on correlation of serum level of C1q tumor necrosis factor-related protein 1 (CTRP1) with coronary atherosclerotic heart disease

Levels of Serum Cystatin C and IL-6 and Its Clinical Significance in Patients with Acute Coronary Syndrome

Prognostic Value of Highly Sensitive C-Reactive Protein and Plaque Morphology in Coronary Artery Disease in China.

The relationship study between serum C-reactive protein and the risk factors of CHD as well as the severity of coronary lesions

Correlation Analysis of Uric Acid and High Sensitivity C-reactive Protein in Patients with Coronary Heart Disease

Correlation between Serum Concentrations of High-sensitivity C-reactive Protein and of β2-microglobulin in Patients with Coronary Heart Disease

The Variation and Significance of Plasma Hs-Crp,il-6 and Sil-6R Levels in Coronary Heart Disease Patients